IDEXX Laboratories stock rises on Q3 beat, narrows FY22 outlook on forex impact
Sundry Photography/iStock Editorial via Getty Images IDEXX Laboratories (NASDAQ:IDXX) stock rose ~7% on Tuesday after Q3 results beat estimates, however, the company narrowed its FY22 outlook. Comparable EPS growth was $2.23, up…